This might be due to the decreased responsiveness of CD8+ T cells to IL-7 in cancers, As previous findings showed that IL-7 did not affect tumor patients derived CD8+ T cell proliferation in vitro [22]. This evidence concerns the gene CD8A and neoplasm.